View in EDS

Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East and Southern Africa: a longitudinal qualitative study.

Saved in:
Bibliographic Details
Title: Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East and Southern Africa: a longitudinal qualitative study.
Authors: Kawuma R; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda. rachel.kawuma@mrcuganda.org., Nakamanya S; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda., Tarimo E; Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Chimukuche RS; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.; Division of Infection & Immunity, University College London, London, UK., Ambindwile J; National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania., Pamba D; National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania., Kusemererwa S; Viral Pathogens and Epidemiology Interventions, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda., Munseri P; Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Singh N; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Dubé K; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA., McCormack S; MRC Clinical Trials Unit, University College London, London, UK., Ruzagira E; Viral Pathogens and Epidemiology Interventions, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Seeley J; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.; Department of Global Health and Development, London School of Tropical Hygiene and Medicine, London, UK.
Corporate Authors: PrEPVacc trial team
Source: Trials [Trials] 2026 May 16; Vol. 27 (1). Date of Electronic Publication: 2026 May 16.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42141483
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East and Southern Africa: a longitudinal qualitative study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kawuma+R%22">Kawuma R</searchLink>; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda. rachel.kawuma@mrcuganda.org.<br /><searchLink fieldCode="AU" term="%22Nakamanya+S%22">Nakamanya S</searchLink>; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Tarimo+E%22">Tarimo E</searchLink>; Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.<br /><searchLink fieldCode="AU" term="%22Chimukuche+RS%22">Chimukuche RS</searchLink>; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.; Division of Infection & Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ambindwile+J%22">Ambindwile J</searchLink>; National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.<br /><searchLink fieldCode="AU" term="%22Pamba+D%22">Pamba D</searchLink>; National Institute for Medical Research-Mbeya Medical Research Centre, Mbeya, Tanzania.<br /><searchLink fieldCode="AU" term="%22Kusemererwa+S%22">Kusemererwa S</searchLink>; Viral Pathogens and Epidemiology Interventions, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.<br /><searchLink fieldCode="AU" term="%22Munseri+P%22">Munseri P</searchLink>; Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.<br /><searchLink fieldCode="AU" term="%22Singh+N%22">Singh N</searchLink>; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Dubé+K%22">Dubé K</searchLink>; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.<br /><searchLink fieldCode="AU" term="%22McCormack+S%22">McCormack S</searchLink>; MRC Clinical Trials Unit, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ruzagira+E%22">Ruzagira E</searchLink>; Viral Pathogens and Epidemiology Interventions, MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Seeley+J%22">Seeley J</searchLink>; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.; Department of Global Health and Development, London School of Tropical Hygiene and Medicine, London, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22PrEPVacc+trial+team%22">PrEPVacc trial team</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101263253%22">Trials</searchLink> [Trials] 2026 May 16; Vol. 27 (1). <i>Date of Electronic Publication: </i>2026 May 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101263253 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1745-6215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217456215%22">17456215 </searchLink><i>NLM ISO Abbreviation: </i>Trials <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42141483
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13063-026-09774-5
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East and Southern Africa: a longitudinal qualitative study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kawuma R
      – PersonEntity:
          Name:
            NameFull: Nakamanya S
      – PersonEntity:
          Name:
            NameFull: Tarimo E
      – PersonEntity:
          Name:
            NameFull: Chimukuche RS
      – PersonEntity:
          Name:
            NameFull: Ambindwile J
      – PersonEntity:
          Name:
            NameFull: Pamba D
      – PersonEntity:
          Name:
            NameFull: Kusemererwa S
      – PersonEntity:
          Name:
            NameFull: Munseri P
      – PersonEntity:
          Name:
            NameFull: Singh N
      – PersonEntity:
          Name:
            NameFull: Dubé K
      – PersonEntity:
          Name:
            NameFull: McCormack S
      – PersonEntity:
          Name:
            NameFull: Ruzagira E
      – PersonEntity:
          Name:
            NameFull: Seeley J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 05
              Text: 2026 May 16
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1745-6215
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Trials
              Type: main
ResultId 1